EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 13.73 +0.15 (1.10%)
Previous Close $13.58    52 Week High
Open $13.62    52 Week Low
Day High $14.01    P/E N/A 
Day Low $13.49    EPS
Volume 842,462